{
    "organizations": [],
    "uuid": "26026e0e6938aa762456c2d8d55e3c8b2e61ce48",
    "author": "",
    "url": "https://www.reuters.com/article/brief-asterias-biotherapeutics-reports-q/brief-asterias-biotherapeutics-reports-q1-loss-per-share-0-04-idUSASC0A150",
    "ord_in_thread": 0,
    "title": "BRIEF-Asterias Biotherapeutics Reports Q1 Loss Per Share $0.04",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " in a minute BRIEF-Asterias Biotherapeutics Reports Q1 Loss Per Share $0.04 Reuters Staff\nMay 9 (Reuters) - Asterias Biotherapeutics Inc:\n* ASTERIAS BIOTHERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND RECENT DEVELOPMENT PROGRESS * Q1 LOSS PER SHARE $0.04\n* Q1 EARNINGS PER SHARE VIEW $-0.13 â€” THOMSON REUTERS I/B/E/S\n* Q1 REVENUE $500,000 VERSUS I/B/E/S VIEW $485,000 Source text for Eikon: ",
    "published": "2018-05-09T23:31:00.000+03:00",
    "crawled": "2018-05-09T23:40:41.045+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "biotherapeutics",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "asterias",
        "biotherapeutics",
        "inc",
        "asterias",
        "biotherapeutics",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "recent",
        "development",
        "progress",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "q1",
        "revenue",
        "versus",
        "view",
        "source",
        "text",
        "eikon"
    ]
}